TORRENT PHARMACEUTICALS
Back to Balance Sheet
|
TORRENT PHARMACEUTICALS Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹1,866 Cr | ₹1,844 Cr | ₹1,944 Cr | ₹1,632 Cr | ₹1,523 Cr |
What is the latest Sundry Debtors ratio of TORRENT PHARMACEUTICALS ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹1,866 Cr |
| Mar2024 | ₹1,844 Cr |
| Mar2023 | ₹1,944 Cr |
| Mar2022 | ₹1,632 Cr |
| Mar2021 | ₹1,523 Cr |
How is Sundry Debtors of TORRENT PHARMACEUTICALS Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,866 Cr | 1.20 | |
| Mar2024 | ₹1,844 Cr | -5.12 | |
| Mar2023 | ₹1,944 Cr | 19.07 | |
| Mar2022 | ₹1,632 Cr | 7.16 | |
| Mar2021 | ₹1,523 Cr | - | |
Compare Sundry Debtors of peers of TORRENT PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| TORRENT PHARMACEUTICALS | ₹140,683.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
| MANKIND PHARMA | ₹85,816.7 Cr | 3% | -3.9% | -15.4% | Stock Analytics | |
TORRENT PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| TORRENT PHARMACEUTICALS | 3.7% |
-4.9% |
26% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses